PR Newswire - 15 Jul 2024
Kyverna's KYV-101 Receives U.S. FDA RMAT Designation for KYV-101 in the Treatment of Patients With Refractory Stiff-Person Syndrome ...
PR Newswire - 20 Jun 2024
Kyverna's KYV-101 Receives U.S. FDA IND Clearance for Treatment of Patients With Treatment-Refractory Stiff-Person Syndrome in the KYSA-8 Phase 2 Trial ...
PR Newswire - 17 Jun 2024
First-in-Disease Use of Kyverna Therapeutics' KYV-101 in Patient With Severe Stiff-Person Syndrome Published in Proceedings of the National Academy of Sciences (PNAS) ...
Business Insider - 07 Aug 2024
I have stiff-person syndrome. It's hard to diagnose and treat, so I plan to travel the country in an RV looking for answers. ...